Literature DB >> 11459687

The prolonged cortical silent period in patients with Huntington's disease.

N Modugno1, A Currà, M Giovannelli, A Priori, F Squitieri, S Ruggieri, M Manfredi, A Berardelli.   

Abstract

OBJECTIVES: In a group of patients with Huntington's disease and age-matched controls, we studied the cortical silent period (SP) elicited by single transcranial magnetic stimulation (TMS) pulses.
METHODS: We measured the area of the pre-stimulus electromyographic (EMG) activity, the area of the motor evoked potentials (MEPs) and the duration of the SP induced by stimuli delivered at an intensity of 150% of motor threshold with a round coil placed over the vertex. We determined the cortical SP by sampling only the 5 traces containing the shortest SPs and by collecting 10 consecutive unselected traces without selecting trials.
RESULTS: Patients and controls had normal EMG background areas, and MEP latencies and areas. Whereas data measured from selected trials gave a normal duration of the SP (patients, 154+/-58 ms; controls, 166+/-22 ms), data from unselected trials yielded a significantly longer SP duration in patients than in controls (356+/-251 vs. 159+/-44 ms) and also a larger variance and range.
CONCLUSIONS: We conclude that in Huntington's disease, an abnormal cortical SP is best sought by collecting unselected consecutive traces. We suggest that the prolonged SP in HD originates from a dysfunction of the mechanisms controlling the restart of voluntary movement after TMS.

Entities:  

Mesh:

Year:  2001        PMID: 11459687     DOI: 10.1016/s1388-2457(01)00599-5

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  7 in total

1.  Repetitive transcranial magnetic stimulation of the motor cortex for hemichorea.

Authors:  V Di Lazzaro; M Dileone; F Pilato; M-F Contarino; G Musumeci; A R Bentivoglio; P A Tonali; J C Rothwell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09       Impact factor: 10.154

Review 2.  Cortical excitability and neurology: insights into the pathophysiology.

Authors:  Radwa A B Badawy; Tobias Loetscher; Richard A L Macdonell; Amy Brodtmann
Journal:  Funct Neurol       Date:  2012 Jul-Sep

Review 3.  Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.

Authors:  Pradip K Kamat; Anuradha Kalani; Philip Kyles; Suresh C Tyagi; Neetu Tyagi
Journal:  Cell Biochem Biophys       Date:  2014-11       Impact factor: 2.194

4.  Abnormal motor cortex excitability in preclinical and very early Huntington's disease.

Authors:  Sven Schippling; Susanne A Schneider; Khailash P Bhatia; Alexander Münchau; John C Rothwell; Sarah J Tabrizi; Michael Orth
Journal:  Biol Psychiatry       Date:  2009-02-07       Impact factor: 13.382

5.  Transcranial magnetic stimulation and brain atrophy: a computer-based human brain model study.

Authors:  Tim Wagner; Uri Eden; Felipe Fregni; Antoni Valero-Cabre; Ciro Ramos-Estebanez; Valerie Pronio-Stelluto; Alan Grodzinsky; Markus Zahn; Alvaro Pascual-Leone
Journal:  Exp Brain Res       Date:  2008-01-10       Impact factor: 1.972

Review 6.  The utility of electrodiagnostic tests for the assessment of medically unexplained weakness and sensory deficit.

Authors:  Josep Valls-Solé
Journal:  Clin Neurophysiol Pract       Date:  2016-04-02

Review 7.  Anatomo-Functional Origins of the Cortical Silent Period: Spotlight on the Basal Ganglia.

Authors:  David Zeugin; Silvio Ionta
Journal:  Brain Sci       Date:  2021-05-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.